{"id":9416,"date":"2025-12-28T22:23:00","date_gmt":"2025-12-28T13:23:00","guid":{"rendered":"https:\/\/japanir.jp\/en\/company\/company-4592\/"},"modified":"2026-08-23T13:19:08","modified_gmt":"2026-08-23T04:19:08","slug":"company-4592","status":"publish","type":"company","link":"https:\/\/japanir.jp\/en\/company\/company-4592\/","title":{"rendered":"SANBIO COMPANY LIMITED"},"content":{"rendered":"","protected":false},"featured_media":0,"template":"","meta":{"Ticker":"4592","DATE":"2025-12-26","longName":"SanBio Company Limited","company_name_ja":"","fullTimeEmployees":33,"address":"","phone":"","website":"https:\/\/www.sanbio.com","industry":"Biotechnology","sector":"Healthcare","regularMarketPrice":1613,"financialCurrency":"","marketCap":125858,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":-52.549999999999997,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":-3794810000,"operatingMargins":0,"NetIncome":-3842612000,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":-28.239999999999998,"recommendationMean":2.6000000000000001,"recommendationKey":"hold","targetMeanPrice":1580,"numberOfAnalystOpinions":5,"analyst_earnings_data":"{\"success\": true, \"fetched_at\": \"2026-08-01T04:42:15.959744\", \"ticker\": \"4592\", \"ticker_full\": \"4592.T\", \"company_name\": \"SANBIO COMPANY LIMITED\", \"analyst_recommendations\": {\"has_data\": true, \"period\": \"3\", \"strong_buy\": 0, \"buy\": 0, \"hold\": 4, \"sell\": 1, \"strong_sell\": 0, \"total_analysts\": 5, \"recommendation_key\": \"hold\", \"recommendation_mean\": 2.6}, \"target_prices\": {\"has_data\": true, \"current\": 919.0, \"high\": 2000.0, \"low\": 1200.0, \"mean\": 1580.0, \"median\": 1500.0}, \"earnings_dates\": {\"has_data\": true, \"next_earnings\": {\"date\": \"2026-09-14\", \"eps_estimate\": -4.8, \"eps_actual\": null, \"surprise_pct\": null}, \"future_count\": 1, \"past_earnings\": [{\"date\": \"2026-03-17\", \"eps_estimate\": -20.69, \"eps_actual\": -14.8, \"surprise_pct\": 28.48}, {\"date\": \"2025-12-15\", \"eps_estimate\": -15.35, \"eps_actual\": -9.95, \"surprise_pct\": 35.18}, {\"date\": \"2018-12-14\", \"eps_estimate\": -16.1, \"eps_actual\": -10.18, \"surprise_pct\": 36.77}]}, \"shareholders\": {\"has_data\": true, \"insider_pct\": 24.92, \"institution_pct\": 7.33, \"major_holders\": [{\"label\": \"\", \"value\": 24.92}, {\"label\": \"\", \"value\": 7.33}, {\"label\": \"\", \"value\": 9.76}, {\"label\": \"\", \"value\": 32.0}], \"institutional_holders\": [{\"holder\": \"iShares Trust-iShares Core MSCI EAFE ETF\", \"shares\": 452500, \"date_reported\": \"2026-06-30\", \"pct_held\": 0.58, \"pct_change\": 13.95, \"value\": 415847500}, {\"holder\": \"iShares Trust-iShares MSCI EAFE Small-Cap ETF\", \"shares\": 237800, \"date_reported\": \"2026-06-30\", \"pct_held\": 0.3, \"pct_change\": -0.34, \"value\": 218538200}, {\"holder\": \"SPDR INDEX SHARES Fd.S-State Street SPDR PORT. Developed World ex-US E\", \"shares\": 187500, \"date_reported\": \"2026-06-30\", \"pct_held\": 0.24, \"pct_change\": 0.0, \"value\": 172312500}, {\"holder\": \"College Retirement Equities Fd.-College Retirement Equities Fd. - Tota\", \"shares\": 174900, \"date_reported\": \"2026-03-31\", \"pct_held\": 0.22, \"pct_change\": 3.25, \"value\": 160733100}, {\"holder\": \"iShares Trust-iShares Core MSCI International Developed Markets ETF\", \"shares\": 85700, \"date_reported\": \"2026-06-30\", \"pct_held\": 0.11, \"pct_change\": 18.53, \"value\": 78758300}, {\"holder\": \"TIAA-CREF Funds-Nuveen Quant International Small Cap Equity Fund\", \"shares\": 67700, \"date_reported\": \"2026-04-30\", \"pct_held\": 0.09, \"pct_change\": -4.11, \"value\": 62216300}, {\"holder\": \"Fidelity Salem Street Trust-Fidelity Total International Index Fund\", \"shares\": 29100, \"date_reported\": \"2026-06-30\", \"pct_held\": 0.04, \"pct_change\": 0.0, \"value\": 26742900}, {\"holder\": \"SPDR INDEX SHARES Fd.S-State Street SPDR S&P Intl Small Cap ETF\", \"shares\": 24100, \"date_reported\": \"2026-06-30\", \"pct_held\": 0.03, \"pct_change\": 1.26, \"value\": 22147900}, {\"holder\": \"STATE STREET Inst. INVESTMENT TRT-State Street Global All Cap Eqy. ex-\", \"shares\": 15300, \"date_reported\": \"2026-03-31\", \"pct_held\": 0.02, \"pct_change\": 0.0, \"value\": 14060700}, {\"holder\": \"Fidelity Concord Street TRT-Fidelity SAI Intl Small Cap Index Fd.\", \"shares\": 16000, \"date_reported\": \"2026-05-31\", \"pct_held\": 0.02, \"pct_change\": 4.58, \"value\": 14704000}], \"mutualfund_holders\": []}}","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"SanBio Company Limited engages in the development, production, and sale of regenerative cell medicines for the central nervous system in Japan and the United States. It develops SB623 that has completed a phase 2 clinical trial to treat traumatic brain injury. The company's research pipeline products also comprise SB623 for chronic disease, age-related macular degeneration, retinitis pigmentosa, spinal cord injury, Parkinson's disease, Alzheimer's disease, etc.; SB618 to treat peripheral nerve damage; SB308 for muscular dystrophy disease; MSC1 for cancer; and MSC2 for inflammatory disease and optic neuritis. The company was founded in 2001 and is headquartered in Tokyo, Japan.","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"financial_data":"","detailed_financial_data":"{\"success\": true, \"fetched_at\": \"2026-08-23T02:49:40.447576\", \"ticker\": \"4592\", \"ticker_full\": \"4592.T\", \"company_name\": \"SANBIO COMPANY LIMITED\", \"company_info\": {\"name_en\": \"SANBIO COMPANY LIMITED\", \"long_name\": \"SanBio Company Limited\", \"sector\": \"Healthcare\", \"industry\": \"Biotechnology\", \"website\": \"https:\/\/www.sanbio.com\", \"employees\": 33, \"country\": \"Japan\", \"city\": \"Tokyo\", \"address\": \"St. Luke Tower\", \"description\": \"SanBio Company Limited engages in the development, production, and sale of regenerative cell medicines for the central nervous system in Japan and the United States. It develops SB623 that has completed a phase 2 clinical trial to treat traumatic brain injury. The company's research pipeline products also comprise SB623 for chronic disease, age-related macular degeneration, retinitis pigmentosa, spinal cord injury, Parkinson's disease, Alzheimer's disease, etc.; SB618 to treat peripheral nerve damage; SB308 for muscular dystrophy disease; MSC1 for cancer; and MSC2 for inflammatory disease and optic neuritis. The company was founded in 2001 and is headquartered in Tokyo, Japan.\"}, \"price_trend\": {\"ma_5\": {\"ma_value\": 1010.6, \"deviation\": -0.06, \"trend\": \"down\"}, \"ma_25\": {\"ma_value\": 985.96, \"deviation\": 2.44, \"trend\": \"up\"}, \"ma_75\": {\"ma_value\": 1202.44, \"deviation\": -16.0, \"trend\": \"down\"}, \"ma_200\": {\"ma_value\": 1718.86, \"deviation\": -41.24, \"trend\": \"down\"}}, \"financials\": {\"years\": [{\"year\": 2026, \"revenue\": 0.0, \"revenue_fmt\": \"N\/A\", \"gross_profit\": 0, \"gross_profit_fmt\": \"N\/A\", \"operating_income\": -3794810000.0, \"operating_income_fmt\": \"-\u00a538\u5104\", \"ebit\": -4256224000.0, \"ebit_fmt\": \"-\u00a543\u5104\", \"net_income\": -3842612000.0, \"net_income_fmt\": \"-\u00a538\u5104\", \"eps\": -52.55, \"operating_margin\": 0, \"total_assets\": 15621539000.0, \"total_assets_fmt\": \"\u00a5156\u5104\", \"total_equity\": 13604667000.0, \"total_equity_fmt\": \"\u00a5136\u5104\", \"total_debt\": 1238700000.0, \"total_debt_fmt\": \"\u00a512\u5104\", \"total_cash\": 15083233000.0, \"total_cash_fmt\": \"\u00a5151\u5104\", \"equity_ratio\": 87.09, \"de_ratio\": 0.09, \"current_ratio\": 28.99, \"operating_cf\": -3760890000.0, \"operating_cf_fmt\": \"-\u00a538\u5104\", \"investing_cf\": -231044000.0, \"investing_cf_fmt\": \"-\u00a52\u5104\", \"financing_cf\": 15962690000.0, \"financing_cf_fmt\": \"\u00a5160\u5104\", \"free_cf\": -3793691000.0, \"free_cf_fmt\": \"-\u00a538\u5104\", \"net_margin\": 0, \"roe\": -28.24, \"roa\": -24.6}, {\"year\": 2025, \"revenue\": 0.0, \"revenue_fmt\": \"N\/A\", \"gross_profit\": 0, \"gross_profit_fmt\": \"N\/A\", \"operating_income\": -3516092000.0, \"operating_income_fmt\": \"-\u00a535\u5104\", \"ebit\": -3002351000.0, \"ebit_fmt\": \"-\u00a530\u5104\", \"net_income\": -2882885000.0, \"net_income_fmt\": \"-\u00a529\u5104\", \"eps\": -40.48, \"operating_margin\": 0, \"total_assets\": 3447339000.0, \"total_assets_fmt\": \"\u00a534\u5104\", \"total_equity\": 1762922000.0, \"total_equity_fmt\": \"\u00a518\u5104\", \"total_debt\": 397000000.0, \"total_debt_fmt\": \"\u00a54\u5104\", \"total_cash\": 2921402000.0, \"total_cash_fmt\": \"\u00a529\u5104\", \"equity_ratio\": 51.14, \"de_ratio\": 0.23, \"current_ratio\": 4.56, \"operating_cf\": -3603106000.0, \"operating_cf_fmt\": \"-\u00a536\u5104\", \"investing_cf\": -4267000.0, \"investing_cf_fmt\": \"-\u00a54.3M\", \"financing_cf\": 2091005000.0, \"financing_cf_fmt\": \"\u00a521\u5104\", \"free_cf\": -3607997000.0, \"free_cf_fmt\": \"-\u00a536\u5104\", \"net_margin\": 0, \"roe\": -163.53, \"roa\": -83.63}, {\"year\": 2024, \"revenue\": 0.0, \"revenue_fmt\": \"N\/A\", \"gross_profit\": 0, \"gross_profit_fmt\": \"N\/A\", \"operating_income\": -4539729000.0, \"operating_income_fmt\": \"-\u00a545\u5104\", \"ebit\": -2531587000.0, \"ebit_fmt\": \"-\u00a525\u5104\", \"net_income\": -2644332000.0, \"net_income_fmt\": \"-\u00a526\u5104\", \"eps\": -40.48, \"operating_margin\": 0, \"total_assets\": 5047291000.0, \"total_assets_fmt\": \"\u00a550\u5104\", \"total_equity\": 2792398000.0, \"total_equity_fmt\": \"\u00a528\u5104\", \"total_debt\": 665000000.0, \"total_debt_fmt\": \"\u00a57\u5104\", \"total_cash\": 4454716000.0, \"total_cash_fmt\": \"\u00a545\u5104\", \"equity_ratio\": 55.32, \"de_ratio\": 0.24, \"current_ratio\": 5.45, \"operating_cf\": -4765654000.0, \"operating_cf_fmt\": \"-\u00a548\u5104\", \"investing_cf\": -19028000.0, \"investing_cf_fmt\": \"-\u00a519.0M\", \"financing_cf\": 2370532000.0, \"financing_cf_fmt\": \"\u00a524\u5104\", \"free_cf\": -4820623000.0, \"free_cf_fmt\": \"-\u00a548\u5104\", \"net_margin\": 0, \"roe\": -94.7, \"roa\": -52.39}, {\"year\": 2023, \"revenue\": 0.0, \"revenue_fmt\": \"N\/A\", \"gross_profit\": 0, \"gross_profit_fmt\": \"N\/A\", \"operating_income\": -7899308000.0, \"operating_income_fmt\": \"-\u00a579\u5104\", \"ebit\": -4672173000.0, \"ebit_fmt\": \"-\u00a547\u5104\", \"net_income\": -5559584000.0, \"net_income_fmt\": \"-\u00a556\u5104\", \"eps\": -95.99, \"operating_margin\": 0, \"total_assets\": 7045114000.0, \"total_assets_fmt\": \"\u00a570\u5104\", \"total_equity\": 4428909000.0, \"total_equity_fmt\": \"\u00a544\u5104\", \"total_debt\": 933000000.0, \"total_debt_fmt\": \"\u00a59\u5104\", \"total_cash\": 6732775000.0, \"total_cash_fmt\": \"\u00a567\u5104\", \"equity_ratio\": 62.86, \"de_ratio\": 0.21, \"current_ratio\": 6.39, \"operating_cf\": -7434147000.0, \"operating_cf_fmt\": \"-\u00a574\u5104\", \"investing_cf\": -10100000.0, \"investing_cf_fmt\": \"-\u00a510.1M\", \"financing_cf\": 9445783000.0, \"financing_cf_fmt\": \"\u00a594\u5104\", \"free_cf\": -7442150000.0, \"free_cf_fmt\": \"-\u00a574\u5104\", \"net_margin\": 0, \"roe\": -125.53, \"roa\": -78.91}, {\"year\": 2022, \"revenue\": 0, \"revenue_fmt\": \"N\/A\", \"gross_profit\": 0, \"gross_profit_fmt\": \"N\/A\", \"operating_income\": 0, \"operating_income_fmt\": \"N\/A\", \"ebit\": 0, \"ebit_fmt\": \"N\/A\", \"net_income\": 0, \"net_income_fmt\": \"N\/A\", \"eps\": 0, \"operating_margin\": 0, \"total_assets\": 0, \"total_assets_fmt\": \"N\/A\", \"total_equity\": 0, \"total_equity_fmt\": \"N\/A\", \"total_debt\": 0, \"total_debt_fmt\": \"N\/A\", \"total_cash\": 0, \"total_cash_fmt\": \"N\/A\", \"equity_ratio\": 0, \"de_ratio\": 0, \"current_ratio\": 0, \"operating_cf\": 0, \"operating_cf_fmt\": \"N\/A\", \"investing_cf\": 0, \"investing_cf_fmt\": \"N\/A\", \"financing_cf\": 0, \"financing_cf_fmt\": \"N\/A\", \"free_cf\": 0, \"free_cf_fmt\": \"N\/A\", \"net_margin\": 0, \"roe\": 0, \"roa\": 0}], \"has_data\": true}, \"dividends\": {\"history\": [], \"has_data\": false}}","ma_5_value":0,"ma_5_deviation":0,"ma_5_trend":"","ma_25_value":0,"ma_25_deviation":0,"ma_25_trend":"","ma_75_value":0,"ma_75_deviation":0,"ma_75_trend":"","ma_200_value":0,"ma_200_deviation":0,"ma_200_trend":"","previousClose":0,"open":0,"dayHigh":0,"dayLow":0,"volume":0,"averageVolume":0,"revenueGrowth":0},"sector":[],"class_list":["post-9416","company","type-company","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.7 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>SANBIO COMPANY LIMITED - Japan IR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/japanir.jp\/en\/company\/company-4592\/\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/japanir.jp\/en\/company\/company-4592\/\",\"url\":\"https:\/\/japanir.jp\/en\/company\/company-4592\/\",\"name\":\"SANBIO COMPANY LIMITED - Japan IR\",\"isPartOf\":{\"@id\":\"https:\/\/japanir.jp\/en\/#website\"},\"datePublished\":\"2025-12-28T13:23:00+00:00\",\"dateModified\":\"2026-08-23T04:19:08+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/japanir.jp\/en\/company\/company-4592\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/japanir.jp\/en\/company\/company-4592\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/japanir.jp\/en\/company\/company-4592\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/japanir.jp\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"SANBIO COMPANY LIMITED\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/japanir.jp\/en\/#website\",\"url\":\"https:\/\/japanir.jp\/en\/\",\"name\":\"Japan IR\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/japanir.jp\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"SANBIO COMPANY LIMITED - Japan IR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/japanir.jp\/en\/company\/company-4592\/","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/japanir.jp\/en\/company\/company-4592\/","url":"https:\/\/japanir.jp\/en\/company\/company-4592\/","name":"SANBIO COMPANY LIMITED - Japan IR","isPartOf":{"@id":"https:\/\/japanir.jp\/en\/#website"},"datePublished":"2025-12-28T13:23:00+00:00","dateModified":"2026-08-23T04:19:08+00:00","breadcrumb":{"@id":"https:\/\/japanir.jp\/en\/company\/company-4592\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/japanir.jp\/en\/company\/company-4592\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/japanir.jp\/en\/company\/company-4592\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/japanir.jp\/en\/"},{"@type":"ListItem","position":2,"name":"SANBIO COMPANY LIMITED"}]},{"@type":"WebSite","@id":"https:\/\/japanir.jp\/en\/#website","url":"https:\/\/japanir.jp\/en\/","name":"Japan IR","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/japanir.jp\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/company\/9416","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/company"}],"about":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/types\/company"}],"wp:attachment":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/media?parent=9416"}],"wp:term":[{"taxonomy":"sector","embeddable":true,"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/sector?post=9416"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}